ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration

DNA Repair

Volumn 12, Issue 8, 2013, Pages 605-611

  Carlessi, Luigi ^a   Fusar Poli, Elena ^a   De Filippis, Lidia ^b   Delia, Domenico ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

ATM; DNA damage response; Hypoxia; IPS cells; Neural stem cells; Neurodegeneration

Indexed keywords

ATM PROTEIN;

ARTICLE; ATAXIA TELANGIECTASIA; CELL MATURATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEURAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ATM; DNA DAMAGE RESPONSE; HYPOXIA; IPS CELLS; NEURAL STEM CELLS; NEURODEGENERATION;

ANIMALS; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DNA DAMAGE; HUMANS; NERVOUS SYSTEM; NEURAL STEM CELLS; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS;

ATAXIA TELANGIECTASIA;

EID: 84880624619     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.04.013     Document Type: Article

References (50)

1. Chun H.H., Gatti R.A. Ataxia-telangiectasia, an evolving phenotype. DNA Repair 2004, 3:1187-1196.
2. McKinnon.P.J. ATM and the molecular pathogenesis of ataxia telangiectasia. Annu. Rev. Pathol. 2012, 7:303-321.
3. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3:155-168.
4. Lavin M.F., Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007, 6:931-942.
5. Lavin M.F. Ataxia-telangiectasia. From a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
6. Lee Y., McKinnon.P.J. Responding to DNA double strand breaks in the nervous system. Neuroscience 2007, 145:1365-1374.
7. Barzilai A., Biton S., Shiloh Y. The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair 2008, 7:1010-1027.
8. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair 2002, 1:3-25.
9. Liu N., Stoica G., Yan M., Scofield V.L., Qiang W., Lynn W.S., Wong P.K. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab. Invest. 2005, 85:1471-1480.
10. Reliene R., Fischer E., Schiestl R.H. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in ATM-deficient mice. Cancer Res. 2004, 64:5148-5153.
11. Arakawa M., Ushimaru N., Osada N., Oda T., Ishige K., Ito Y. N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. Neurosci. Res. 2006, 55:255-263.
12. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
13. Kruman I.I., Wersto R.P., Cardozo-Pelaez F., Smilenov L., Chan S.L., Chrest F.J., Emokpae R., Gorospe M., Mattson M.P. Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 2004, 41:549-561.
14. Yang Y., Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J. Neurosci. 2005, 25:2522-2529.
15. Boehrs J.K., He J., Halaby M., Yang D. Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells. J. Neurochem. 2007, 100:337-345.
16. Gorodetsky E., Calkins S., Ahn J., Brooks P.J. ATM, the Mre11/Rad50/Nbs1 complex, and topoisomerase I are concentrated in the nucleus of purkinje neurons in the juvenile human brain. DNA Repair 2007, 6:1698-1707.
17. Li J., Han Y.R., Plummer M.R., Herrup K. Cytoplasmic ATM in neurons modulates synaptic function. Curr. Biol. 2009, 19:2091-2096.
18. Li J., Chen J., Ricupero C.L., Hart R.P., Schwartz M.S., Kusnecov A., Herrup K. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat. Med. 2012, 18:783-790.
19. Barzilai A. The neuro-glial-vascular interrelations in genomic instability symptoms. Mech. Ageing Dev. 2011, 132:395-404.
20. Villa A., Navarro-Galve B., Bueno C., Franco S., Blasco M.A., Martinez-Serrano.A. Long-term molecular and cellular stability of human neural stem cell lines. Exp. Cell Res. 2004, 294:559-570.
21. Pollock K., Stroemer P., Patel S., Stevanato L., Hope A., Miljan E., Dong Z., Hodges H., Price J., Sinden J.D. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol. 2006, 199:143-155.
22. Donato R., Miljan E.A., Hines S.J., Aouabdi S., Pollock K., Patel S., Edwards F.A., Sinden J.D. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 2007, 8:36.
23. De Filippis L., Lamorte G., Snyder E.Y., Malgaroli A., Vescovi A.L. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells 2007, 25:2312-2321.
24. Rota Nodari L., Ferrari D., Giani F., Bossi M., Rodriguez-Menendez V., Tredici G., Delia D., Vescovi A.L., De Filippis L. Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS ONE 2010, 5:e14035.
25. Ferrari D., Zalfa C., Rota Nodari L., Gelati M., Carlessi L., Delia D., Vescovi A., De Filippis L. Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model. Cell. Mol. Life Sci. 2012, 68:1193-1210.
26. Carlessi L., De Filippis L., Lecis D., Vescovi A., Delia D. DNA-damage response, survival and differentiation in vitro of a human neural stem cell line in relation to ATM expression. Cell Death Differ. 2009, 16:795-806.
27. Biton S., Gropp M., Itsykson P., Pereg Y., Mittelman L., Johe K., Reubinoff B., Shiloh Y. ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells. DNA Repair 2007, 6:128-134.
28. Adams B.R., Golding S.E., Rao R.R., Valerie K. Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS ONE 2010, 5:e10001.
29. Delia D., Carlessi L., Fusar Poli E. Establishment of induced pluripotent stem (IPS) cells from A-T patient and characterization of the neural-specified progeny. ATW 2012, 14th International Workshop on Ataxia-Telangiectasia 2012.
30. Nayler S., Gatei M., Kozlov S., Gatti R., Mar J.C., Wells C.A., Lavin M., Wolvetang E. Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Trans. Med. 2012, 1:523-535.
31. Kim S.U., Nagai A., Nakagawa E., Choi H.B., Bang J.H., Lee H.J., Lee M.A., Lee Y.B., Park I.H. Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol. Biol. 2008, 428:103-121.
32. Hitomi M., Stacey D.W. The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons. Cytometry Part A 2010, 77A:524-533.
33. Gilad S., Chessa L., Khosravi R., Russell P., Galanty Y., Piane M., Gatti R.A., Jorgensen T.J., Shiloh Y., Bar-Shira A. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am. J. Hum. Genet. 1998, 62:551-561.
34. Daniel J.A., Pellegrini M., Lee B.S., Guo Z., Filsuf D., Belkina N.V., You Z., Paull T.T., Sleckman B.P., Feigenbaum L., Nussenzweig A. Loss of ATM kinase activity leads to embryonic lethality in mice. J. Cell Biol. 2012, 198:295-304.
35. Coufal N.G., Garcia-Perez J., Peng G.E., Marchetto M.C.N., Muotri A.R., Mu Y., Carson C.T., Macia A., Moran J.V., Gage F.H. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20382-20387.
36. McKinnon.P.J. DNA repair deficiency and neurological disease. Nat. Rev. Neurosci. 2009, 10:100-112.
37. Biton S., Dar I., Mittelman L., Pereg Y., Barzilai A., Shiloh Y. Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. J. Biol. Chem. 2006, 281:17482-17491.
38. Panchision D.M. The role of oxygen in regulating neural stem cells in development and disease. J. Cell. Physiol. 2009, 220:562-568.
39. De Filippis L., Delia D. Hypoxia in the regulation of neural stem cells. Cell. Mol. Life Sci. 2011, 68:2831-2844.
40. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem. Sci. 2010, 35:505-513.
41. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 2009, 21:894-899.
42. Takai H., Wang R.C., Takai K.K., Yang H., de Lange T. Tel2 regulates the stability of PI3K-related protein kinases. Cell 2007, 131:1248-1259.
43. Xiong H., Xia K., Li B., Zhao G., Zhang K.ChI.P1.Z. A potential modulator to GABAergic system. Acta Biochim. Biophys. Sin. (Shanghai) 2009, 41:295-300.
44. Zhang C.P., Zhu L.L., Zhao T., Zhao H., Huang X., Ma X., Wang H., Fan M. Characteristics of neural stem cells expanded in lowered oxygen and the potential role of hypoxia-inducible factor-1Alpha. Neurosignals 2006, 15:259-265.
45. Fernando R.N., Eleuteri B., Abdelhady S., Nussenzweig A., Andang M., Ernfors P. Cell cycle restriction by histone H2AX limits proliferation of adult neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5837-5842.
46. Andang M., Hjerling-Leffler J., Moliner A., Lundgren T.K., Castelo-Branco G., Nanou E., Pozas E., Bryja V., Halliez S., Nishimaru H., Wilbertz J., Arenas E., Koltzenburg M., Charnay P., El Manira A., Ibanez C.F., Ernfors P. Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. Nature 2008, 451:460-464.
47. Perry T.L., Kish S.J., Hinton D., Hansen S., Becker L.E., Gelfand E.W. Neurochemical abnormalities in a patient with ataxia-telangiectasia. Neurology 1984, 34:187-191.
48. Gazulla J., Benavente I., Sarasa Barrio M. Adult-onset ataxia-telangiectasia. A clinical and therapeutic observation. Neurologia 2006, 21:447-451.
49. Santilli G., Lamorte G., Carlessi L., Ferrari D., Nodari L.R., Binda E., Delia D., Vescovi A.L., De Filippis L. Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS ONE 2010, 5:e8575.
50. Jakel R.J., Schneider B.L., Svendsen C.N. Using human neural stem cells to model neurological disease. Nat. Rev. Genet. 2004, 5:136-144.